Interestingly, a recent study demonstrated that ovarian cancer-derived exosomes could transfer CD44 to human peritoneal mesothelial cells (HPMCs) and induce morphologic change in HPMCs to a mesenchymal, spindle phenotype. The gene discussed is CD44; the disease is ovarian cancer.